ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 17th, 2014 • Amarantus Bioscience Holdings, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 17th, 2014 Company IndustryThis ASSET PURCHASE AGREEMENT, dated November 6, 2014 (the “Agreement”), is by and among Amarantus Bioscience Holdings, Inc., a Nevada corporation (“Amarantus”), Regenicin, Inc., a Nevada corporation (“Regenicin”), Clark Corporate Law Group, LLP (fka Cane Clark, LLP, hereinafter “CCLG”), and Gordon & Rees, LLP (“Gordon & Rees”). The parties identified above are sometimes hereinafter individually referred to as a “Party” and collectively as the “Parties”.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 17th, 2014 • Regenicin, Inc. • Industrial & commercial fans & blowers & air purifing equip
Contract Type FiledNovember 17th, 2014 Company IndustryThis ASSET PURCHASE AGREEMENT, dated November 7, 2014 (the “Agreement”), is by and among Amarantus Bioscience Holdings, Inc., a Nevada corporation (“Amarantus”), Regenicin, Inc., a Nevada corporation (“Regenicin”), Clark Corporate Law Group, LLP (fka Cane Clark, LLP, hereinafter “CCLG”), and Gordon & Rees, LLP (“Gordon & Rees”). The parties identified above are sometimes hereinafter individually referred to as a “Party” and collectively as the “Parties”.